Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Presynaptic glutamatergic terminals are the specialized distal endings of axons that release glutamate, the primary excitatory neurotransmitter in the vertebrate central nervous system [1]. These terminals contain the machinery necessary for glutamate synthesis, packaging into synaptic vesicles via vesicular glutamate transporters (VGLUTs), and calcium-dependent exocytosis into the synaptic cleft [2]. They are critical for excitatory signaling and synaptic plasticity, which underlie learning and memory [3]. Dysregulation of these terminals, leading to either excessive glutamate release (excitotoxicity) or insufficient transmission, is implicated in various neurological and psychiatric disorders, including epilepsy, stroke, and schizophrenia [4]. Pharmacological intervention often focuses on modulating release through presynaptic receptors (e.g., mGluRs) or ion channels (e.g., N-type calcium channels) to restore normal glutamatergic tone [5, 6].
Modulation of glutamate release via inhibition of voltage-gated calcium channels (e.g., N-type or P/Q-type), binding to synaptic vesicle proteins (SV2A), or activation of inhibitory presynaptic metabotropic glutamate receptors (autoreceptors).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Presynaptic glutamatergic terminal.